3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
13
Urinary Bladder Neoplasms
11
Ovarian Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Lymphoma, Large B-Cell, Diffuse
4
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urologic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Gemcitabine
×
30 days
×
Clear all
No trials found.